Capital Guardian Asset Management »

Progenics Pharmaceuticals shares owned by Capital Guardian Asset Management

Quarter-by-quarter ownership of Progenics Pharmaceuticals shares owned by Capital Guardian Asset Management from 13F filings

Historical chart of Capital Guardian Asset Management investment in Progenics Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Progenics Pharmaceuticals held by Capital Guardian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Progenics Pharmaceuticals by Capital Guardian Asset Management

Quarter filed Position value Share count Share price at filing
2016-12-31 $151k 18k 8.63
2016-09-30 $206k 33k 6.34
2016-06-30 $137k 33k 4.22
2016-03-31 $172k 40k 4.35
2015-12-31 $359k 59k 6.14
2015-09-30 $1.4M 244k 5.72